These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 35547630

  • 1. Statistical Parametric Mapping in Amyloid Positron Emission Tomography.
    Smith NM, Ford JN, Haghdel A, Glodzik L, Li Y, D'Angelo D, RoyChoudhury A, Wang X, Blennow K, de Leon MJ, Ivanidze J.
    Front Aging Neurosci; 2022; 14():849932. PubMed ID: 35547630
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [Abstract] [Full Text] [Related]

  • 5. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
    Moon S, Kim S, Mankhong S, Choi SH, Vandijck M, Kostanjevecki V, Jeong JH, Yoon SJ, Park KW, Kim EJ, Yoon B, Kim HJ, Jang JW, Hong JY, Park DH, Shaw LM, Kang JH.
    Alzheimers Res Ther; 2021 Jan 12; 13(1):22. PubMed ID: 33436035
    [Abstract] [Full Text] [Related]

  • 6. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
    Xie Q, Ni M, Gao F, Dai LB, Lv XY, Zhang YF, Shi Q, Zhu XX, Xie JK, Shen Y, Wang SC.
    ACS Chem Neurosci; 2022 May 18; 13(10):1558-1565. PubMed ID: 35476397
    [Abstract] [Full Text] [Related]

  • 7. Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements.
    Nerattini M, Rubino F, Arnone A, Polito C, Mazzeo S, Lombardi G, Puccini G, Nacmias B, De Cristofaro MT, Sorbi S, Pupi A, Sciagrà R, Bessi V, Berti V.
    Neurol Sci; 2022 Apr 18; 43(4):2469-2480. PubMed ID: 34739618
    [Abstract] [Full Text] [Related]

  • 8. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH, Cogo-Moreira H, Rabin JS, Black SE, Swardfager W, Alzheimer's Disease Neuroimaging Initiative.
    J Neurosci; 2019 Sep 11; 39(37):7428-7437. PubMed ID: 31350262
    [Abstract] [Full Text] [Related]

  • 9. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
    Grimmer T, Riemenschneider M, Förstl H, Henriksen G, Klunk WE, Mathis CA, Shiga T, Wester HJ, Kurz A, Drzezga A.
    Biol Psychiatry; 2009 Jun 01; 65(11):927-34. PubMed ID: 19268916
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study.
    Okada Y, Kato T, Iwata K, Kimura Y, Nakamura A, Hattori H, Toyama H, Ishii K, Ishii K, Senda M, Ito K, Iwatsubo T, Japanese Alzheimer’s Disease Neuroimaging Initiative.
    Ann Nucl Med; 2020 Feb 01; 34(2):108-118. PubMed ID: 31749127
    [Abstract] [Full Text] [Related]

  • 11. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters.
    Forsberg A, Almkvist O, Engler H, Wall A, Långström B, Nordberg A.
    Curr Alzheimer Res; 2010 Feb 01; 7(1):56-66. PubMed ID: 20205671
    [Abstract] [Full Text] [Related]

  • 12. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging.
    Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Wyffels L, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C, Ribbens A, Bjerke M, Stroobants S, Engelborghs S, Staelens S.
    Neuroimage Clin; 2019 Feb 01; 22():101771. PubMed ID: 30927601
    [Abstract] [Full Text] [Related]

  • 13. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 14. Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer's disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study.
    Motta C, Di Donna MG, Bonomi CG, Assogna M, Chiaravalloti A, Mercuri NB, Koch G, Martorana A.
    Alzheimers Res Ther; 2023 Aug 30; 15(1):144. PubMed ID: 37649105
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O.
    JAMA Neurol; 2014 Oct 30; 71(10):1282-9. PubMed ID: 25155658
    [Abstract] [Full Text] [Related]

  • 16. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
    Pérez-Grijalba V, Arbizu J, Romero J, Prieto E, Pesini P, Sarasa L, Guillen F, Monleón I, San-José I, Martínez-Lage P, Munuera J, Hernández I, Buendía M, Sotolongo-Grau O, Alegret M, Ruiz A, Tárraga L, Boada M, Sarasa M, AB255 Study Group.
    Alzheimers Res Ther; 2019 Dec 01; 11(1):96. PubMed ID: 31787105
    [Abstract] [Full Text] [Related]

  • 17. In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings.
    Formaglio M, Costes N, Seguin J, Tholance Y, Le Bars D, Roullet-Solignac I, Mercier B, Krolak-Salmon P, Vighetto A.
    J Neurol; 2011 Oct 01; 258(10):1841-51. PubMed ID: 21479849
    [Abstract] [Full Text] [Related]

  • 18. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC.
    Neuroimage Clin; 2014 Oct 01; 4():604-14. PubMed ID: 24936411
    [Abstract] [Full Text] [Related]

  • 19. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.
    Oliveira F, Leuzy A, Castelhano J, Chiotis K, Hasselbalch SG, Rinne J, Mendonça A, Otto M, Lleó A, Santana I, Johansson J, Anderl-Straub S, Arnim C, Beer A, Blesa R, Fortea J, Sanna-Kaisa H, Portelius E, Pannee J, Zetterberg H, Blennow K, Moreira AP, Abrunhosa A, Nordberg A, Castelo-Branco M.
    Neuroimage Clin; 2018 Oct 01; 20():603-610. PubMed ID: 30186764
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.